Profile
ABEO VRTX REGN ALNY SGEN ARGX
Company Name Abeona Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $328.43M $117.98B $59.32B $43.28B $43.15B $40.50B
Employees 0.14K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Vishwas Seshadri Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ABEO VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 4
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Buy
Trading
ABEO VRTX REGN ALNY SGEN ARGX
Last Close $6.26 $366.54 $563 $438.93 $228.74 $661.83
High 52 $6.86 $516.74 $1201.76 $438.93 $228.74 $690.32
Low 52 $4.18 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High -8.75 % -29.07 % -53.15 % 0 % 0 % -4.13 %
Price vs. 52 Week Low 49.76 % 0 % 16.58 % 95.44 % 0 % 28.7 %
Total Return
ABEO VRTX REGN ALNY SGEN ARGX
1 Month Return 7.38 % -23.47 % 1.9 % 36.86 % 0 % 19.21 %
3 Month Return 18.79 % -13.75 % 6.67 % 74.77 % 0 % 20.41 %
6 Month Return 11.19 % -21.9 % -20.65 % 58.92 % 0 % 2.35 %
9 Month Return -2.19 % -29.07 % -32.04 % 58.21 % 0 % 11.05 %
YTD Return 12.39 % -8.98 % -20.96 % 86.53 % 0 % 7.61 %
1 Year Return 41.63 % -21.75 % -50.23 % 62.86 % 0 % 23.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABEO VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -19.18 % -3.53 % 4.37 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
ABEO VRTX REGN ALNY SGEN ARGX
Asset Growth 70.2 % -0.87 % 14.15 % 10.71 % -1.21 % 36.55 %
Gross Profit Growth -100 % 10.25 % 8.23 % 26.81 % 22.93 % 77.08 %
Revenue Growth -100 % 11.66 % 8.27 % 22.97 % 24.65 % 78.6 %
Revenue 3 Year -100 % 45.6 % -13.44 % 147.1 % 91.56 % 275.84 %
Revenue 5 Year - 163.93 % 82.78 % 775.72 % 215.48 % 1701.04 %
Revenue 10 Year -100 % 1632.15 % 429.43 % 2487.4 % 494.04 % 5950.81 %
EBIT Growth -26.36 % -93.69 % 13.17 % 24.59 % - 128.87 %
Net Income Growth -17.62 % -114.8 % 11.61 % 36.82 % 9.51 % 382.34 %
Net Income 3 Yeari Growth Per Share 93.1 % -122.89 % -46.47 % 69.73 % -763.59 % 274.39 %
Net Income 5 Yeari Growth Per Share 95.92 % -145.38 % 111.07 % 73.13 % -276.93 % 396.61 %
Net Income 10 Yeari Growth Per Share 97.62 % 33.84 % 1232.49 % 55.09 % -624.16 % 938.02 %
Operating Income Growth -36.23 % -106.08 % -1.39 % 37.31 % 10.13 % 94.91 %
Operating Cash Flow Growth (CFG) -51.36 % -113.93 % -3.78 % -107.98 % 9.07 % 80.31 %
Operating 3 Year CFG 91.82 % -118.65 % -38.85 % 98.8 % -147.99 % 88.36 %
Operating 5 Year CFG 95.62 % -131.3 % 84.11 % 97.44 % -195.86 % -135.21 %
Operating 10 Year CFG 65.28 % 12.43 % 517.51 % 97.08 % -2622.09 % -64 %
EPS Growth 38.74 % -114.8 % 10.39 % 38.64 % 10.81 % 369.77 %
EPS Diluted Growth 38.74 % -114.97 % 10.27 % 38.64 % 10.81 % 347.67 %
Book Value Per Share 54.69 % -6.59 % 11.76 % 129.75 % -9.83 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -90.03 % 62.6 % 53.21 % -89.42 % 33.72 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -98.79 % 168.85 % 167.88 % -96.01 % 220.81 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -90.87 % 1265.7 % 1113.59 % -95.83 % 691.19 % 1039.11 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share -100 % - - - - -
Debt Growth 326.81 % 116.42 % 0.06 % 2.27 % -23.28 % 95.27 %
Free Cash Flow Growth -56.56 % -124.1 % -0.08 % -201.54 % 3.67 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ABEO VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 87.44 % 86.01 % 79.1 % 65.32 %
Return on Assets TTM -44.47 % -4.32 % 11.67 % -6.4 % -16.61 % 15.06 %
Return on Equity TTM -86.45 % -6.25 % 14.43 % -509.33 % -20.8 % 18.96 %
Return on Capital Employed TTM -85.53 % -3.89 % 11.12 % -3.68 % -21.46 % 5.04 %
Net Income Per EBT TTM 100 % 329.41 % 91.46 % 75.89 % 101.33 % 237.3 %
EBT Per Ebit TTM 63.48 % 40.44 % 126.92 % 308.03 % 98.26 % 147.38 %
EBIT Per Revenue TTM - -6.69 % 27.02 % -4.91 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM -249.74 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 1.91
Payables Turnover TTM 0.33 3.49 2.47 3.37 1.97 0.88
Inventory Turnover TTM - 1.14 0.56 5.01 0.96 2.21
Fixed Asset Turnover TTM - 421.34 % 293.64 % 337.41 % 665.41 % 5009.77 %
Asset Turnover TTM - 48.51 % 37.19 % 55.72 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM -1.2 -3.82 45.13 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -1.27 -4.9 36.58 -0.58 -2.88 -1.09
Cash Per Share TTM 169.06 % 2413.86 % 7107.14 % 2024.29 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 33.37 % -1.92 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.21 % 128.33 % 81.05 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -249.74 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM -5.21 -93.78 15.43 -574.08 -81.26 -521.84
Price To Operating Cash Flows Ratio TTM -5.34 -120.39 12.38 -954.11 -93.1 -618.62
Price Cash Flow Ratio TTM -5.34 -120.39 12.38 -954.11 -93.1 -618.62
Income Statement (TTM)
ABEO VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $-0.06B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -1.55 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ABEO VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.02B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.06B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.04B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.07B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.02B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.11B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
ABEO VRTX REGN ALNY SGEN ARGX
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.95
AARD Aardvark Therapeutics, Inc. Common Stock 11.99
ABCL AbCellera Biologics Inc. 4.25
ABCM Abcam plc 23.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.36
ABPWW 0.0368
ABSI Absci Corporation 2.84
ABUS Arbutus Biopharma Corporation 3.4
ABVC ABVC BioPharma, Inc. 2.7
ABVX Abivax SA American Depositary Shares 70.13
ACAD ACADIA Pharmaceuticals Inc. 24.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.621
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.5
ACIU AC Immune SA 2.14
ACLX Arcellx, Inc. 70.5
ETFs With Exposure to ABEO
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0114 220.32
VTI Vanguard Total Stock Market Index Fund 0.00039 313.03
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.001 139.02
IWN iShares Russell 2000 Value ETF 0.00121 161.07
IWO iShares Russell 2000 Growth ETF 0.02027 291.54
VXF Vanguard Extended Market Index Fund 0.00398 196.6
HDG ProShares Hedge Replication ETF 0.00141987 50.1395
UWM ProShares Ultra Russell2000 0.00840463 38.89
VTHR Vanguard Russell 3000 Index Fund 0.00062 280.682
IWC iShares Micro-Cap ETF 0.07894 131.82
URTY ProShares UltraPro Russell2000 0.00696844 40.98
VTWV Vanguard Russell 2000 Value Index Fund 0.00104 141.927
VTWG Vanguard Russell 2000 Growth Index Fund 0.01762 212.693
VTWO Vanguard Russell 2000 Index Fund 0.00955 89.09
XAW.TO iShares Core MSCI All Country World ex Canada Index ETF 0 47.73
XUU.TO iShares Core S&P U.S. Total Market Index ETF 0 64.46
XUH.TO iShares Core S&P U.S. Total Market Index ETF (CAD-Hedged) 0 51.62
XTR.TO iShares Diversified Monthly Income ETF 0 11.43
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 42.05
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.0005 106.44
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 106.42
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00023 50.81
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00023 50.8
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.81
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
XBAL.TO iShares Core Balanced ETF Portfolio 0 31.68
XCNS.TO iShares Core Conservative Balanced ETF Portfolio 0 24.43
XEQT.TO iShares Core Equity ETF Portfolio 0 36.67
XGRO.TO iShares Core Growth ETF Portfolio 0 32.6
XINC.TO iShares Core Income Balanced ETF Portfolio 0 20.83
DFAT Dimensional U.S. Targeted Value ETF 0 54.58
DFAS Dimensional U.S. Small Cap ETF 0.00020616 64.48
DFAC Dimensional U.S. Core Equity 2 ETF 0 36.81
VTSAX Vanguard Total Stock Market Index Fund 0 152.35
R2US.L SPDR Russell 2000 US Small Cap UCITS ETF 0.012009 64.22
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00398 149.14
VITSX Vanguard Total Stock Market Index Fund 0 152.38
IBRN iShares Neuroscience and Healthcare ETF 0.67659 23.582
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000165995 107.79
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00398 149.15
ZPRR.DE SPDR Russell 2000 US Small Cap UCITS ETF 0.012009 55.01
R2SC.L SPDR Russell 2000 US Small Cap UCITS ETF 0.012009 47.75
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
SURI Simplify Propel Opportunities ETF 5.35771 15.07
VEMPX Vanguard Extended Market Index InstlPlus 0.00398 368.04
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00039 285.84
RSSL Global X Funds 0.01 86.51
Unlock